New search | Conferencedetail
Print view

Gene Therapy Immunogenicity - Virtual Summit

Evvnt Promotion / evvnt
04.08.2020 - 06.08.2020  Online
Time: 08:00 - 17:30
Conference themes
Immunogenicity compromises both the efficacy and safety of gene therapies and thus represents one of the most prominent challenges that must be overcome in the field. Uniting translational, clinical, regulatory and manufacturing gene therapy functions, the inaugural Gene Therapy Immunogenicity Summit is the industry's definitive meeting enabling you to better measure, modulate and predict immune response and drive transformative treatments through the clinic to patients
Professional congress organizer (PCO)
Hanson Wade

Speakers: Barry Byrne, Professor and Associate Chairman, University of Florida, Mark Milton, Area Head of Ophthalmology, Novartis, Sander van Deventer, Executive Vice President, uniQure and more.

Enquiries and Registration:
Mr. Customer Service
General Medicine
Congress fees
Conference Ticket (1st Release): USD 1399.0, Conference Ticket (2nd Release): USD 1599.0, Conference Ticket (3rd Release): USD 1799.0, Conference Ticket (Final Release): USD 1999.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Swiss Tropical and Public Health InstituteÖsterreichisches Rotes KreuzAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAnästhesie in Entwicklungsländern e. V.Alumni Club Medizinische Universität WienOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation European Health Forum GasteinCenter of Excellence